Alligator Bioscience AB (0RK9)
LSE
0.0234
+0.0010 (+4.46%)
Real-time Data
07:00 AM
Day's Range
0.02340.0234
52 wk Range
0.02245.42
Financial Statements - 0RK9 - Alligator Bioscience AB
Revenue
428.56M▲ 34.6%
Net Income
-19.50M▲ 55.2%Net Margin -4.6%
EBITDA
77.35M▲ 65.3%
Free Cash Flow
24.01M▲ 141.7%
Income Statement
| Period Ending | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|
| Sales | 428.56M | 318.38M | 254.82M |
| Cost of Goods | 170.59M | 145.53M | 122.25M |
| Gross Profit | 257.96M | 172.84M | 132.56M |
 Operating Expense | - | - | - |
| Operating Income | -11.18M | -15.79M | -29.90M |
| Non-Operating Interest | - | - | - |
| Other Income Expense | -3.27M | -13.25M | -336K |
| Pre Tax Income | -18.20M | -42.65M | -39.59M |
| Income Tax | 1.30M | 911K | 793K |
| Net Income | -19.50M | -43.56M | -40.39M |
| EPS Basic | -0.21 | -0.5 | -0.46356 |
| EPS Diluted | -0.21 | -0.5 | -0.46356 |
| Basic Shares Outstanding | 93.22M | 87.13M | 87.13M |
| Diluted Shares Outstanding | 93.22M | 87.13M | 87.13M |
| Ebit | - | - | - |
| Ebitda | 77.35M | 46.78M | 32.84M |
| Net Income Continuous Operations | -19.50M | -43.56M | -40.39M |
| Minority Interests | - | - | - |
| Preferred Stock Dividends | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
